Suppr超能文献

干扰素在临床放射治疗中的应用

Utility of interferons in clinical radiotherapy.

作者信息

Mossman K L, Hill L T, Dritschilo A

出版信息

J Natl Med Assoc. 1982 Nov;74(11):1083-7.

Abstract

Interferons are being tested in the treatment of a wide range of malignancies. Clinical experience has indicated that interferons may have relatively few side effects compared to other commonly used antineoplastic agents. In addition, they have shown activity as radiation response modifiers in various experimental systems. Thus, as natural biological compounds, interferons may prove to be superior to other radiation response modifiers now on clinical trial in radiotherapy. In this paper radiation-interferon interactions are reviewed and the evaluation of the usefulness of interferons as an adjuvant in radiotherapy is discussed.

摘要

干扰素正在多种恶性肿瘤的治疗中进行测试。临床经验表明,与其他常用的抗肿瘤药物相比,干扰素的副作用可能相对较少。此外,在各种实验系统中,它们已显示出作为辐射反应调节剂的活性。因此,作为天然生物化合物,干扰素可能被证明优于目前正在放疗临床试验中的其他辐射反应调节剂。本文综述了辐射与干扰素的相互作用,并讨论了干扰素作为放疗辅助剂的效用评估。

相似文献

3
The role of radiosensitizing drugs in the management of cancer.
Invest Cell Pathol. 1979 Oct-Dec;2(4):303-8.
4
Altering the response to radiation: sensitizers and protectors.改变对辐射的反应:增敏剂和防护剂。
Semin Oncol. 2014 Dec;41(6):848-59. doi: 10.1053/j.seminoncol.2014.09.013. Epub 2014 Oct 7.
5
Radiation modifiers: treatment overview and future investigations.辐射修饰剂:治疗概述与未来研究
Hematol Oncol Clin North Am. 2006 Feb;20(1):119-39. doi: 10.1016/j.hoc.2006.01.012.
6
Interferons: biological and clinical effects.干扰素:生物学及临床效应
Semin Surg Oncol. 1989;5(6):391-401. doi: 10.1002/ssu.2980050605.
7
International Clinical Trials in Radiation Oncology. Chemical modifiers.
Int J Radiat Oncol Biol Phys. 1988;14 Suppl 1:S39-49.
9
Radiation Modifiers.辐射调节剂。
Hematol Oncol Clin North Am. 2019 Dec;33(6):1041-1055. doi: 10.1016/j.hoc.2019.08.004. Epub 2019 Sep 17.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验